Global Vaccines Innovation and Immunology Conference

Date: September 21-23, 2026
Location: London, UK & Online
Event Type: Hybrid

About the Conference

The Global Vaccines Innovation and Immunology Conference (GVX 2026) brings together leading specialists in immunology, biotechnology, and public health to explore current trends in vaccine research. This hybrid event offers participants the opportunity to expand their knowledge on emerging technologies and analytical approaches while engaging with peers in both in-person and virtual settings.

Key Topics

GVX 2026 will cover a wide range of topics, including:

• RNA therapeutics
• Antigen optimization
• Vector refinement
• Immunity modeling

Participants will also gain insights into:

• Laboratory automation
• Predictive analytics
• High-throughput experimentation
• Data-driven decision frameworks

Focus Areas

The conference emphasizes:

• Regulatory compliance
• Ethical deployment
• Global-access strategies
• Distribution planning

Attendees will have the opportunity to refine methodologies, analyze solutions for real-world applications, and explore innovative approaches to vaccine research and development.

Hands-On Demonstrations

Interactive sessions will feature:

• AI-supported laboratory platforms
• Molecular diagnostics
• Delivery innovations
• Automated instrumentation
• Advanced formulation techniques

These demonstrations aim to help attendees integrate cutting-edge technologies into their work, improving precision, reliability, and operational quality.

Benefits of Participation

By attending GVX 2026, professionals will:

• Enhance their understanding of cross-disciplinary solutions
• Develop effective problem-solving approaches
• Gain exposure to technological and methodological advancements

The conference provides a platform for engagement, discussion, and applied knowledge transfer, ensuring participants acquire tools to:

• Strengthen research capabilities
• Implement effective strategies
• Advance public-health initiatives worldwide

Join GVX 2026 to connect with experts, explore innovative solutions, and contribute to the future of vaccine research and immunology!